Evidence map›Paper›PMID 41552148›Full record

ArticleCureus2025

Recanalization of the PRESERFLO MicroShunt With a 9-0 Nylon Suture: A Case Report.

Mao Ishiyama, Yuta Kitamura, Tomoaki Tatsumi, Takayuki Baba

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mao IshiyamaDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN.
Yuta KitamuraDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN.
Tomoaki TatsumiDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN.
Takayuki BabaDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical studies have evaluated the safety and efficacy of PRESERFLO MicroShunt (PMS) (Santen Pharmaceutical, Osaka, Japan) implantation, suggesting that this surgery is associated with fewer serious complications and significant intraocular pressure (IOP) reduction. Although there have been reports of iris obstruction at the tip of the tube, no cases of luminal occlusion at the mid-portion of the tube or its management have been reported. This case report describes a 57-year-old man who underwent PMS for primary open-angle glaucoma (POAG) in the right eye. One month after surgery, the IOP in the right eye had increased to nearly 40 mmHg. Initial needling around the distal end of the tube was attempted but proved ineffective. We then examined the tube lumen using anterior segment optical coherence tomography (AS-OCT), which revealed a suspected luminal obstruction at the center of the tube. Upon removal of the tube, intraluminal tissue debris was found at the center of the lumen. A 9-0 nylon suture was inserted into the lumen to dislodge and remove the debris, after which the tube was reinserted. Postoperatively, a well-formed filtration bleb was observed, and the IOP decreased to 8 mmHg. One year after surgery, the IOP in the right eye remained stable at 12 mmHg, with no evidence of re-occlusion of the tube. The insertion of a 9-0 nylon suture may be an effective method for clearing luminal debris in PMS tubes. In addition, AS-OCT is a useful tool for detecting tube lumen obstructions.

Indexed as

as-octelevated intraocular pressureglaucomaintraocular pressurepreserflo microshuntsurgical complication

Identifiers

PMID41552148
PMCPMC12810073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.